Douglas G Janzen, Chairman & Chief Executive Officer at Aequus Pharmaceuticals, holds 12.55M shares in Aequus Pharmaceuticals (Ticker: TSE:AQS), holds 182.50K shares in Correvio Pharma (Ticker: CORV), holds 38.89K shares in Neovasc (Ticker: NVCN). Most recently, Douglas G Janzen Bought ― shares of Aequus Pharmaceuticals on Dec 01, 2022 for an estimated value of 14.85K.
What is the percentage of profitable transactions made by Douglas G Janzen?
The percentage of profitable transactions made by Douglas G Janzen is 19%.
What is the average return per transaction made by Douglas G Janzen?
The average return per transaction made by Douglas G Janzen is -21.40%.
What stocks does Douglas G Janzen hold?
Douglas G Janzen holds: TSE:AQS, CORV, MSCLF, NVCN, TSE:PINK stocks.
What was Douglas G Janzen’s latest transaction?
Douglas G Janzen latest transaction was an Informative Buy of C$14.85K.
What was Douglas G Janzen's most profitable transaction?
Douglas G Janzen’s most profitable transaction was an Informative Sell of NVCN stock on November 24, 2015. The return on the trade was 88.80%.
What is Douglas G Janzen's role in Aequus Pharmaceuticals?
Douglas G Janzen's role in Aequus Pharmaceuticals is Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.